Conditions: Hypertrophic Cardiomyopathy
Keywords: chest pain dyspnea
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 14
Healthy volunteers: no

Brief summary:
The purpose of RHYME is to evaluate the safety and efficacy of ranolazine in Hypertrophic Cardiomypathy patients with chest pain or dyspnea despite treatment with standard medical therapy. This is a small, pilot, open-label (non-randomized) study of an approved drug for the treatment of angina in a novel patient population (adult patient population with hypertrophic cardiomyopathy).

Detailed description:

Arms:
arm 1: Ranolazine, 500 mg for 60 days

Interventions: intervention 1: Ranolazine
Intervention descriptions: intervention 1: None

Protocol document: